Clinical Trial: Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects (INTORACT)

Sponsor and Collaborators
Wyeth

Contact
Contact: Pfizer CT.gov Call Center
1-800-718-1021
ClinicalTrials.gov_Inquiries@pfizer.com


Continue Reading

Principal Investigator
Study Director: Pfizer CT.gov Call Center

ClinicalTrials.gov Identifier

NCT00631371